GME
66
-5
LMT
30
-2
CINF
53
3
CMS
60
2
GLW
45
-3
IFF
47
-4
TXN
43
-5
XYL
35
-2
DTE
43
5
ZBH
65
3
KIM
72
2
AZO
50
-5
CAH
48
-6
GS
72
4
EQT
51
-3
MCO
71
-7
HSY
31
-6
MCD
52
-5
TEL
60
-8
WU
24
4
GME
66
-5
LMT
30
-2
CINF
53
3
CMS
60
2
GLW
45
-3
IFF
47
-4
TXN
43
-5
XYL
35
-2
DTE
43
5
ZBH
65
3
KIM
72
2
AZO
50
-5
CAH
48
-6
GS
72
4
EQT
51
-3
MCO
71
-7
HSY
31
-6
MCD
52
-5
TEL
60
-8
WU
24
4
Financhill
Back

abrdn Global Infrastructure Income Fund Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
62

ASGI
abrdn Global Infrastructure Income Fund

Last Price:
19.67
Seasonality Move:
5.73%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.94
Seasonality Move:
17.03%
Buy
62
abrdn Global Infrastructure Income Fund (ASGI) is a Buy

Is abrdn Global Infrastructure Income Fund a Buy, Sell or Hold?

  • The current abrdn Global Infrastructure Income Fund [ASGI] share price is $19.23. The Score for ASGI is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ASGI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ASGI Stock Price Chart

What is abrdn Global Infrastructure Income Fund's stock price today?

  • The abrdn Global Infrastructure Income Fund share price today is $19.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASGI is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

ASGI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 38.37 Sell
Chaikin Money Flow: 39580 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.34 - 20.12) Sell
Bollinger Bands (100): (18.81 - 19.97) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

ASGI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.24 Sell
20-day SMA: 19.64 Sell
50-day SMA: 19.84 Sell
200-day SMA: 18.62 Buy
8-day EMA: 19.29 Sell
20-day EMA: 19.52 Sell
50-day EMA: 19.62 Sell
200-day EMA: 18.85 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

abrdn Global Infrastructure Income Fund Earnings Growth & ASGI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

abrdn Global Infrastructure Income Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):